IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10689354 B1

PDFFull Text
Date of Patent:
Jun. 23, 2020

Filed:

Dec. 09, 2016

Aminoazole derivative

Applicant:

Teijin Pharma Limited, Tokyo, JP;

Inventors:

Shinnosuke Hosoda, Tokyo, JP;

Gen Unoki, Tokyo, JP;

Hidekazu Watanabe, Tokyo, JP;

Kosuke Sasaki, Tokyo, JP;

Jun Shibata, Tokyo, JP;

Emi Yokoyama, Tokyo, JP;

Kyohei Horie, Tokyo, JP;

Kenichiro Takagi, Tokyo, JP;

Assignee:

Teijin Pharma Limited, Chiyoda-ku, Tokyo, JP;

Attorney:

Sughrue Mion, PLLC

Primary Examiner:

Emily A Bernhardt

Assistant Examiner:

Laura M Daniel

Int. Cl.
CPC ...
C07D 263/48 (2006.01); C07C 335/12 (2006.01); A61K 31/421 (2006.01); A61P 5/26 (2006.01); C07D 277/56 (2006.01); C07C 335/18 (2006.01); C07D 249/08 (2006.01); C07D 417/12 (2006.01); A61K 31/4725 (2006.01); A61K 31/498 (2006.01); A61K 31/428 (2006.01); A61K 31/426 (2006.01); A61K 31/497 (2006.01); A61K 31/427 (2006.01); A61K 31/4439 (2006.01); A61K 31/454 (2006.01); A61K 31/4709 (2006.01); A61K 31/4245 (2006.01); C07D 413/12 (2006.01); A61K 31/422 (2006.01); C07D 277/82 (2006.01); A61K 31/501 (2006.01); A61K 31/433 (2006.01); A61K 31/5377 (2006.01);
U.S. Cl.
CPC ...
C07D 277/56 (2013.01); A61K 31/421 (2013.01); A61K 31/422 (2013.01); A61K 31/426 (2013.01); A61K 31/427 (2013.01); A61K 31/428 (2013.01); A61K 31/4245 (2013.01); A61K 31/433 (2013.01); A61K 31/4439 (2013.01); A61K 31/454 (2013.01); A61K 31/4709 (2013.01); A61K 31/4725 (2013.01); A61K 31/497 (2013.01); A61K 31/498 (2013.01); A61K 31/501 (2013.01); A61K 31/5377 (2013.01); A61P 5/26 (2018.01); C07C 335/12 (2013.01); C07C 335/18 (2013.01); C07D 249/08 (2013.01); C07D 263/48 (2013.01); C07D 277/82 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01);
Abstract

A compound, represented by the following formula or a medically acceptable salt thereof, having an effect of regulating the activity of an androgen receptor. In the formula, X represents S, O; Z represents (R)-A-(CRR)—(CRR); A represents aryl, heteroaryl; Rrepresents alkyl, cycloalkyl, alkenyl, alkynyl, alkoxyalkyl, aryl, arylalkyl, heterocycle, heterocyclic alkyl; Rrepresents hydrogen, halogen, alkyl, cycloalkyl, phenyl; R3 represents hydrogen, halogen, alkyl, cycloalkyl, alkoxyalkyl, alkenyl, alkynyl, cycloalkenyl, aryl, arylalkyl, heterocycle, heterocyclic alkyl, acyl, cycloalkylcarbonyl, benzoyl, spiroalkyl, adamantyl, silyl, RRNCO—; Rand Rrepresent hydrogen, halogen, alkyl, phenyl, and cycloalkyl.

Find Patent Forward Citations

Loading…